Literature DB >> 6146262

Brain peptide regulation of adrenal epinephrine secretion.

M R Brown, L A Fisher.   

Abstract

The studies described in this paper support the hypothesis that specific brain peptides may act as neurochemical substrates for the differential patterns of sympathetic nervous system and adrenomedullary responses to various provocative stimuli. Different treatments, e.g., exposure to ether vapor or cold, hemorrhage or hypoglycemia, elicit stimulus-specific changes in plasma concentrations of epinephrine and norepinephrine. Likewise, several neuropeptides, e.g., bombesin, corticotropin-releasing factor, thyrotropin-releasing factor, and somatostatin-related peptides, act within the central nervous system to produce differential changes in the relative concentrations of epinephrine and norepinephrine in plasma. The possibility that these peptides may be involved in generating stimulus-specific changes in plasma catecholamine concentrations following various physiological and pharmacological treatments is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146262     DOI: 10.1152/ajpendo.1984.247.1.E41

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Synthesis of nitric oxide in the dorsal motor nucleus of the vagus mediates the inhibition of gastric acid secretion by central bombesin.

Authors:  B Beltrán; M D Barrachina; A Méndez; E Quintero; J V Esplugues
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal man.

Authors:  D S Goldstein; A Breier; O M Wolkowitz; D Pickar; J W Lenders
Journal:  Clin Auton Res       Date:  1992-12       Impact factor: 4.435

3.  Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats.

Authors:  A Stengel; M Goebel-Stengel; L Wang; A Luckey; E Hu; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2011-05-13       Impact factor: 3.598

4.  Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice.

Authors:  A Stengel; M Goebel-Stengel; L Wang; M Larauche; J Rivier; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2011-06       Impact factor: 3.598

Review 5.  Gastrin-releasing peptide links stressor to cancer progression.

Authors:  Xinqiu Li; Yunfu Lv; Aihua Yuan; Zongfang Li
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-06       Impact factor: 4.553

6.  Investigation of the central sites at which morphine acts to cause hypertension in conscious rabbits.

Authors:  C N May; C J Whitehead; M R Dashwood; C J Mathias
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

7.  Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.

Authors:  D H Wasserman; H L Lickley; M Vranic
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

Review 8.  Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2012-12-31       Impact factor: 3.750

9.  Mechanism of glucoregulatory responses to stress and their deficiency in diabetes.

Authors:  P D Miles; K Yamatani; H L Lickley; M Vranic
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

10.  Blockade of Rostral Ventrolateral Medulla (RVLM) Bombesin Receptor Type 1 Decreases Blood Pressure and Sympathetic Activity in Anesthetized Spontaneously Hypertensive Rats.

Authors:  Izabella S Pinto; Aline A Mourão; Elaine F da Silva; Amanda S Camargo; Stefanne M Marques; Karina P Gomes; James O Fajemiroye; Angela A da Silva Reis; Ana C S Rebelo; Marcos L Ferreira-Neto; Daniel A Rosa; André H Freiria-Oliveira; Carlos H Castro; Eduardo Colombari; Diego B Colugnati; Gustavo R Pedrino
Journal:  Front Physiol       Date:  2016-06-02       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.